CS-2013

N/A

Report date: 2025/07/17 15:35:02

Base Information

Drug NameCS-2013
Drug Alias NameCS-2013CS2013
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionB-cell-activating factor/B lymphocyte stimulator inhibitorsTumor necrosis factor ligand superfamily member 13 inhibitors
TargetsB-cell-activating factor/B lymphocyte stimulatorTumor necrosis factor ligand superfamily member 13
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCstone Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesCstone Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A